Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-14

FDA Approved: HEPZATO KIT — Original Application (Delcath Systems, Inc.)

View source ↗

Summary

The FDA approved HEPZATO KIT, a lyophilized melphalan hydrochloride injection, for isolated hepatic perfusion in adults with unresectable liver metastases from …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPZATO KIT (melphalan hydrochloride injection, lyophilized, for solution)

Snippet

ORIG AP for HEPZATO KIT (MELPHALAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION)